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EXECUTIVE SUMMARY  
Supply Chain Management at the  
National Naval Medical Center Pharmacy  
 
 
The National Naval Medical Center (NNMC) in Bethesda, Maryland is the U.S. 
Navy’s flagship of medical centers and is the Navy’s third-largest medical center.1  NNMC 
provides medical services to approximately 46,000 patients annually,2 and its pharmacy has 
an annual budget of $46M for drugs dispensed to NNMC patients.3  This consulting project, 
completed with the support of the NNMC Pharmacy Department Head and facilitated 
through the Naval Postgraduate School Executive MBA Program, applied operations 
management and supply chain management principles to the processes used by the NNMC 
pharmacy to find potential efficiency improvements. 
 
Specifically, the consultant team evaluated drug purchasing data from the Defense 
Medical Logistics Supply System (DMLSS) and dispensing data from the Composite 
Healthcare System (CHCS) for specific high-cost and high-volume drugs to identify optimal 
inventory levels and order points.  The NNMC Pharmacy Staff selected the following six 
drugs for analysis: 
 
 Arimedex (anastrozole) – a breast cancer prevention drug. 
 Intelence (extravirine) – an HIV treatment drug.   
 Procrit (epoetin alfa)  – an anemia treatment drug. 
 Seroquel (quetiapine) – depressive disorder (bipolar & schizophrenia) 
treatment drug. 
 Topamax (topiramate) – an anti-seizure/epilepsy medication. 
 Vfend (voriconazole) – fungus and yeast infection treatment drug. 
                                                 
1 NNMC Public Affairs Document “National Naval Medical Center at a Glance,” 
www.bethesda.med.navy.mil   
2 Ibid. 
3 Personal Interview with LT Bradley Gotto, 29 July 2010 
 After analyzing historical ordering and dispensing data for these drugs and touring the 
NNMC drug storage facilities, the consultant team’s primary recommendation is that NNMC 
pharmacy should  adjust re-order points, re-order quantities, and safety stock for the subject 
drugs to reduce high levels of inventory and unnecessary safety stock. Since the NNMC 
pharmacy can obtain drugs at low cost with minimal (1 day) lead time, NNMC can reduce 
the average inventory of these drugs and shift the burden of inventory management to the 
drug suppliers.  This has potential to simplify the restocking process at the NNMC pharmacy 
and reduce the manpower required to fill new orders.  Other secondary recommendations to 
improve the NNMC Pharmacy operations include: 
 
 Perform a full inventory of drugs held at the NNMC Pharmacy to develop a 
full accounting of all drugs on hand. 
 Expand analysis to determine required safety stock for other drugs. 
 Promote adoption of a consolidated system to replace DMLSS and CHCS to 




CDR Thinh Ha 
LCDR Benjamin Schwartz 
LT Bradley Gotto 
Brian Harvey 
 
The consultant team greatly appreciates the time and effort dedicated to our research by our 
interviewees and the pharmacy staff at NNMC.  Their expertise and patience were critical to 
our team’s ability to perform an outside assessment of the NNMC Pharmacy ordering system 
and was vital in helping us identify potential process improvements. 
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I. INTRODUCTION AND BACKGROUND  
A. INTRODUCTION 
In a recent speech, Defense Secretary Robert Gates stated that “health-care costs are 
eating the Defense Department alive.”4  The Defense Department is actively pursuing ways 
to cut health care costs across the board.  Although the Pharmacy at the National Naval 
Medical Center (NNMC) in Bethesda, Maryland makes up only about 10% of the total 
NNMC budget,5 even moderate cost savings at the pharmacy could be helpful to NNMC, the 
Navy, and the Defense Department as a whole.   
 
In this project, the consultant team evaluated the processes used by the NNMC 
Pharmacy in procuring, storing, and dispensing drugs to find potential efficiency 
improvements.  The consultant team applied operations management and supply chain 
management principles to attempt to reduce overall pharmacy costs by optimizing inventory 
levels of specific drugs.   
 
B. BACKGROUND 
The National Naval Medical Center (NNMC) in Bethesda, Maryland is the U.S. 
Navy’s flagship of medical centers and is the Navy’s third-largest medical center.6  NNMC 
provides medical services to approximately 46,000 patients annually,7 and its pharmacy has 
an annual budget of $46M for drugs dispensed to NNMC patients.8  The majority of planning 
and budgeting for the pharmacy is based upon historical demand with limited application of 
formal forecasting models or statistical analysis; therefore, there may be potential for savings 
by applying supply chain management strategies to the procurement, storage, and dispensing 
of drugs at NNMC. 
 
                                                 
4 Robert Gates Speech at Eisenhower Library in Abilene Kansas 8 May 2010, 
www.defense.gov/speeches/speech.aspx?speechid=1467 
5 Personal Interview with LT Bradley Gotto, 29 July 2010 
6 NNMC Public Affairs Document “National Naval Medical Center at a Glance,” 
www.bethesda.med.navy.mil   
7 Ibid. 
8 Personal Interview with LT Bradley Gotto, 29 July 2010 
C. PROJECT OBJECTIVES 
This project’s goal was to analyze the ordering and dispensing data for six highly 
utilized or high cost drugs at NNMC, determine if a more effective process for ordering and 
storing the drugs exists, and recommend any applicable process improvements to the NNMC 
Pharmacy Staff.   
 
D. PROJECT SCOPE 
The project scope was limited to six drugs identified by the NNMC Pharmacy Staff as 
being expensive on a per-pill basis, highly utilized, or both.  Although the scope of the 
analysis is limited to these drugs, there is the potential to apply best practices to other drugs 
in the system as well.  The NNMC Pharmacy Staff suggested study of the following drugs: 
 
 Arimedex (anastrozole) – a breast cancer prevention drug. 
 Intelence (extravirine) – an HIV treatment drug.   
 Procrit (epoetin alfa)  – an anemia treatment drug. 
 Seroquel (quetiapine) – depressive disorder (bipolar & schizophrenia) 
treatment drug. 
 Topamax (topiramate) – an anti-seizure/epilepsy medication. 
 Vfend (voriconazole) – fungus and yeast infection treatment drug. 
 
This analysis was not intended as a critique of the NNMC Pharmacy’s current 
processes; the analysis represents recommendations only designed to inform the command 
about potential process improvements.  Additionally, due to intricacies of the Navy funding 
cycle, there are certain end-of-year and mid-year drug purchases that may skew data analysis.  
For that reason, these mid-year and end-of-year purchases were not taken into account when 
attempting to quantify potential cost savings.  The analysis was limited to inventory control 








1.  Conduct Interviews with NNMC Pharmacy Staff 
The Consultant Team met with the NNMC Pharmacy Department Head, CDR Thinh 
Ha and two of his staff pharmacists, LT Bradley Gotto and LCDR Benjamin Schwartz to 
discuss the NNMC Pharmacy process and tour the NNMC pharmaceutical storage facility.   
2.  Collect historical Data on Drug Ordering and Dispensing Data 
Data was requested on the target drugs, and NNMC Pharmacy Staff provided the data 
in spreadsheets so that it could be analyzed for trends in ordering and stock levels. Ordering 
information for each drug was provided from the Defense Medical Logistics Standard 
Support System (DMLSS) and demand (or dispensing) information was supplied from the 
Composite Health Care System (CHCS).  Pharmacy Supply Petty Officers order and receive 
drugs in DMLSS.  Doctors write prescriptions in CHCS which are filled by the command 
pharmacists.   These two systems are not interconnected and do not share data. 
3.  Evaluate Stock Levels and Ordering Points  
The ordering and dispensing data were compared to see how much stock was carried 
for each drug.  The stock levels were evaluated to determine whether the stock could be 
reduced without undue risk of stock out (i.e., running out of a given drug).   
4.  Identify Alternative Order Points and Compare to Existing Process for 
Potential Savings 
NNMC and vendor policies were evaluated to determine whether making more 
frequent orders of smaller drug quantities could save money relative to the existing order 
timing and quantities.  This method of drug buying would reduce the required inventory 
carried at NNMC by allowing for more frequent, smaller orders to cover the demand with a 
much smaller safety stock than is currently carried.   
5.  Provide Recommendations Based on the Most Cost Effective Process 
If cost savings can be realized, we recommend a trial period for reducing inventory 
levels to recommended re-order points and re-order quantities based upon this report’s 
findings.  We also  recommend further studies be conducted on other drugs in the NNMC 
pharmacy to see what additional cost savings can be realized with optimal re-order points and 
re-order quantities based upon set service levels.   
II. ASSUMPTIONS AND RESULTS 
A. ASSUMPTIONS 
The vendor’s contract states that there is a one day turnaround for orders. Based on 
our interview with the NNMC staff and their comments about past vendor performance, our 
study factored in some variability in lead time.  It was assumed that deliveries require one 
day 75% of the time, two days 10% of the time, three days 10% of the time, and 5% of the 
orders require up to 7 days to fill which sometimes requires finding a secondary vendor.  




Using the DMLSS and CHCS data provided by NNMC, profiles for each of the 
subject drugs were created.  These profiles show the Service Levels, re-ordering frequency, 
and costs associated with current inventory policy.  The Service Level is a measure of how 
much risk exists that a particular drug will “stock out” (not be available) during any 
individual inventory cycle.  Higher service levels indicate a lower risk of stock out, but 
require more inventory to sit on the shelf.  This inventory, called safety stock, compensates 
for variability in demand while waiting to receive replenishment stock and for variability in 
the time it takes to receive the replenishment stock (lead time).9  Options that can be utilized 
to increase Service Level, reduce costs, or adjust re-ordering frequency are also presented.   
 
1. Arimidex (generic Anastrozole) 
 
Figure 1a shows that the NNMC currently maintains an inventory of Arimidex that 
approximates the 99.99% Service Level.  On average, the NNMC places an order for 
Arimidex every 11 days.   
 
                                                 
9 Simchi-Levi, E; Kaminsky, P; and Simchi-Levi, E.  (2008)  Designing and Managing 
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Figure 1b shows the cost to maintain this Service Level is an average of $12,258 
worth of inventory on the shelf.   This figure can also be used to select an alternate Service 
Level and approximate re-ordering interval to realize cost savings or manpower savings.  For 
example, selecting a Service Level of 99% and an order interval of 2 weeks would result in a 




Current Service Level = ~99.99%
Avg $ value on shelf = $12,258
Avg order interval (weeks) = 1.5
Approximate order interval
1 week 2 weeks 4 weeks
Service Level = 99% 8,052.76$    10,380.68$  15,036.52$  
Service Level = 99.9% 9,895.52$    12,223.44$  16,879.28$  
Service Level = 99.99% 11,222.31$  13,550.23$  18,206.07$  





 Figure 1c shows the re-order points, re-order quantities, and required safety stock 
associated with the given Service Levels and approximate ordering intervals. 
 
ARIMIDEX Re-Order Point / Re-Order Quantity
1 week 2 weeks 4 weeks
Service Level = 99% 41  /  28 41  /  56 41  /  112 34.4
Service Level = 99.9% 52  /  28 52  /  56 52  /  112 45.5






 2. Intelence (extravirine) 
  
Figure 2a shows that the NNMC currently maintains an inventory of Intelence that 
approximates the 99.99% Service Level.  On average, the NNMC places an order for 









$1,000 $2,000 $3,000 $4,000





















) Service Level = 99%
Service Level = 99.9%
Service Level = 99.99%





Figure 2b shows the cost to maintain this Service Level is an average of $3,189 worth 
of inventory on the shelf.   This figure can also be used to select an alternate Service Level 
and approximate re-ordering interval to realize cost savings or manpower savings.  For 
example, selecting a Service Level of 99% and an order interval of 2 weeks would result in a 
yearly savings of $1,110.  Due to the large quantity (120) of Intelence per unit of order and 




Current Service Level = ~99.99%
Avg $ value on shelf = $3,189
Avg order interval (weeks) = 4.7
Approximate order interval
2 weeks 4 weeks
Service Level = 99% 2,078.51$    2,307.03$    
Service Level = 99.9% 2,600.44$    2,828.96$    
Service Level = 99.99% 2,976.22$    3,204.75$    




  Figure 2c shows the re-order points, re-order quantities, and required safety stock 
associated with the given Service Levels and approximate ordering intervals. 
 
INTELENCE Re-Order Point / Re-Order Quantity
2 weeks 4 weeks
Service Level = 99% 4  /  2 4  /  3 3.5
Service Level = 99.9% 5  /  2 5  /  3 4.7







3. Procrit (epoetin alfa) 
 
Figure 3a shows that the NNMC currently maintains an inventory of Procrit that 
approximates the 99.99% Service Level.  On average, the NNMC places an order for Procrit 











$1,000 $2,000 $3,000 $4,000






















Service Level = 99%
Service Level = 99.9%
Service Level = 99.99%





Figure 3b shows the cost to maintain this Service Level is an average of $3,847 worth 
of inventory on the shelf.   This figure can also be used to select an alternate Service Level 
and approximate re-ordering interval to realize cost savings or manpower savings.  For 
example, selecting a Service Level of 99% and an order interval of 2 weeks would result in a 
yearly savings of $1,835.  
  
PROCRIT
Current Service Level = ~99.99%
Avg $ value on shelf = $3,847
Avg order interval (weeks) = 5.8
Approximate order interval
1 week 2 weeks 4 weeks
Service Level = 99% 1,746.66$    2,011.88$    2,542.32$    
Service Level = 99.9% 2,223.52$    2,488.74$    3,019.18$    
Service Level = 99.99% 2,566.86$    2,832.08$    3,362.52$    





 Figure 3c shows the re-order points, re-order quantities, and required safety stock 
associated with the given Service Levels and approximate ordering intervals. 
 
PROCRIT Re-Order Point / Re-Order Quantity
1 week 2 weeks 4 weeks
Service Level = 99% 3  /  1 3  /  2 3  /  4 2.8
Service Level = 99.9% 4  /  1 4  /  2 4  /  4 3.7







4. Seroquel (quetiapine) 
 
Figure 4a shows that the NNMC currently maintains an inventory of Seroquel that 
approximates the 99% Service Level.  On average, the NNMC places an order for Seroquel 
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Figure 4b shows the cost to maintain this Service Level is an average of $1,485 worth 
of inventory on the shelf.   This figure can also be used to select an alternate Service Level 
and approximate re-ordering interval to realize cost savings or manpower savings.  For 
example, reducing the order interval to 2 weeks would result in a yearly savings of $421.  
  
SEROQUEL
Current Service Level = ~99%
Avg $ value on shelf = $1,485
Avg order interval (weeks) = 5.8
Approximate order interval
1 week 2 weeks 4 weeks
Service Level = 99% 985.39$       1,064.18$    1,300.53$    
Service Level = 99.9% 1,251.86$    1,330.65$    1,567.00$    
Service Level = 99.99% 1,443.72$    1,522.50$    1,758.86$    





 Figure 4c shows the re-order points, re-order quantities, and required safety stock 
associated with the given Service Levels and approximate ordering intervals. 
 
SEROQUEL Re-Order Point / Re-Order Quantity
1 week 2 weeks 4 weeks
Service Level = 99% 6  /  2 6  /  3 6  /  6 5.3
Service Level = 99.9% 8  /  2 8  /  3 8  /  6 6.9






5. Topamax (Topiramate) 
 
Figure 5a shows that the NNMC currently maintains an inventory of Topamax that 
approximates the 84% Service Level.  On average, the NNMC places an order for Topamax 
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Figure 5b shows the cost to maintain this Service Level is an average of $6,338 worth 
of inventory on the shelf.   This figure can also be used to select an alternate Service Level 
and approximate re-ordering interval to realize cost savings or manpower savings.  For 
example, to increase the Service Level to 99% with an order interval of 2 weeks would cost 
an extra $3,675 per year. 
  
TOPAMAX
Current Service Level = ~84%
Avg $ value on shelf = $6,338
Avg order interval (weeks) = 1.9
Approximate order interval
1 week 2 weeks 4 weeks
Service Level = 84% 4,565.96$    6,461.40$    10,252.28$  
Service Level = 99% 8,117.76$    10,013.20$  13,804.08$  
Service Level = 99.99% 11,562.74$  13,458.18$  17,249.06$  





 Figure 5c shows the re-order points, re-order quantities, and required safety stock 
associated with the given Service Levels and approximate ordering intervals. 
 
TOPAMAX Re-Order Point / Re-Order Quantity
1 week 2 weeks 4 weeks
Service Level = 84% 18  /  19 18  /  38 18  /  76 13.4
Service Level = 99% 36  /  19 36  /  38 36  /  76 31.2








6. Vfend (voriconazole) 
 
Figure 6a shows that the NNMC currently maintains an inventory of Vfend that 
approximates the 96% Service Level.  On average, the NNMC places an order for Vfend 
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Figure 6b shows the cost to maintain this Service Level is an average of $3,704 worth 
of inventory on the shelf.   This figure can also be used to select an alternate Service Level 
and approximate re-ordering interval to realize cost savings or manpower savings.  Switching 
to a one week ordering interval would save approximately $522 per year, but may not be 
worth the additional manpower burden. 
  
VFEND
Current Service Level = ~96%
Avg $ value on shelf = $3,704
Avg order interval (weeks) = 2.1
Approximate order interval
1 week 2 weeks 4 weeks
Service Level = 96% 3,182.42$    3,672.49$    4,652.63$    
Service Level = 99.9% 5,072.08$    5,562.15$    6,542.29$    
Service Level = 99.99% 5,869.28$    6,359.35$    7,339.49$    





 Figure 6c shows the re-order points, re-order quantities, and required safety stock 
associated with the given Service Levels and approximate ordering intervals. 
 
VFEND Re-Order Point / Re-Order Quantity
1 week 2 weeks 4 weeks
Service Level = 96% 42  /  15 42  /  29 42  /  57 38.0
Service Level = 99.9% 69  /  15 69  /  29 69  /  57 64.9





   
 
As illustrated by the preceding figures, each drug has trade-offs that could be made 
by NNMC to either reduce manpower requirements or reduce yearly inventory costs.  In 
general, higher service levels and larger order intervals cost more, while lower service levels 
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III. CONCLUSION AND RECOMMENDATIONS 
A. CONCLUSION 
The primary goal of the NNMC is to attain as close to a 100% service level as 
possible for all drugs that it dispenses.  This is understandable because without the drugs 
required for treatment, doctors are unable to adequately care for service members, veterans 
and their dependents.  This faultless service level, however, comes at a price, as each 
incremental increase in service level requires a larger incremental increase in safety stock.  
Safety stock is inventory beyond that required to fill average demand during the average lead 
time required to replenish the inventory.  Safety stock is required to offset variability caused 
by a possible surge in demand for a drug while waiting to receive it from the vendor, and the 
possibility that the vendor takes longer than promised to deliver the drug. 
The near 100% Service Level goal is also becoming more difficult to achieve as the 
number of patients increase, the cost of drugs increase, and budgets are projected to decrease.  
Further complicating the issue is the lack of a single automated system to manage the 
ordering, inventory control, dispensing, and re-stocking of drugs.  This increases manpower 
requirements and introduces human error into the process.  
Our analysis shows that for some of our sample drugs, the NNMC currently carries 
inventory near that required to maintain a 99.99% service level.  This means that for each 
inventory cycle, there is approximately a .01% chance that a particular drug will be 
unavailable (stock out) when a patient requests it.  This probability is not cumulative and 
does not mean that a stock out must happen .01% of the time at a 99.99% Service Level.  The 
cost associated with achieving this high service level is reflected in additional inventory 
sitting on the shelf.   
Excess inventory should be avoided whenever possible.  It results in unnecessary 
expenditures of dollars that could be used more effectively elsewhere in the pharmacy and/or 
the command.  Additionally, excess inventory may result in inventory being lost in the 
warehouse and/or expired.  Although expired drugs can be returned for credit with the 
vendor, this comes at a significant loss (staff estimates this at approximately 70% of original 
value).  There is a process to extend expirations through the DoD shelf life extension 
program (SLEP), but this is a lengthy and cumbersome process which is normally avoided by 
the pharmacy staff10. 
The analysis also shows that for some of the drugs, the NNMC is currently operating 
at or below the 99% service level.  This is acceptable if the NNMC is willing to accept an 
increased chance that these drugs may stock out during any inventory cycle. In these cases, 
the pharmacy could potentially increase the service level and still save money by ordering 
these drugs more frequently in smaller quantities. The effect on the supply staff’s workload 
would need to be factored into this decision as well.  
  
B. LIMITATIONS 
A limitation realized in the beginning of this project was the number of drugs that 
could be analyzed in the limited time to complete  this report.  Also, as noted by the NNMC 
pharmacy staff, is the fact that CHCS and DMLSS data systems do not share data.  A 
comparison of CHCS data and DMLSS data show that the two systems do not agree on the 
number of drugs that have been dispensed.  As it exists now, drugs that are not picked up by 
patients are returned to inventory but might not be re-entered into the CHCS system (staff 
estimate this at 10% of all drugs dispensed). Additionally, the pharmacy inventory in 
DMLSS is managed by the supply PO’s based upon their periodic visual inspections. Orders 
are based upon these visual inspections and not directly tied to the dispensing system 
(CHCS).  The current system of inventory management is not standardized and increases 
opportunities for errors.  A flow chart of the current process is provided in Appendix A.  
Acquiring a single system that performs all of the required functions to manage the pharmacy 
operations would increase efficiency and reduce the workload of the pharmacy staff.  
The inefficiencies described above introduced anomalies in the data used for this 
analysis.  For example, the data for Topamax, an anti-seizure medication that should have 
stable demand, has a month where demand exceeds 500 units and other months where 
demand is zero.  For that reason, the numerical results presented in this report are 
approximate. 
                                                 
10 Interview with Pharmacy staff dated 27 July 2010 
The calculated Service Level probabilities are based on the inventory policy alone 
and do not take into account events beyond the NNMC’s control.  Events such as a 
nationwide shortage of a drug due to a production problem or a nationwide recall may have 
an effect on the NNMC regardless of the Service Level policy in use. 
 
C. RECOMMENDATIONS 
It is recommended NNMC Pharmacy staff utilize the figures provided in this report to 
adjust re-order points, re-order quantities, and safety stock for the subject drugs to reduce 
high levels of inventory and unnecessary safety stock.  The Pharmacy staff will have to set 
these levels based upon their desired Service Level and manpower availability.  The team 
recommends that NNMC resupply pharmaceuticals on a periodic basis (e.g., weekly or 
monthly).  The periodicity will need to balance manpower required for ordering and 
shelving, which will drive a less frequent ordering schedule, with the inventory costs for a 
particular service level, which will drive a more frequent ordering schedule.  To reduce 
excess inventory and improve efficiencies, the team also recommends that order quantities be 
set to only replenish the volume that was actually dispensed during the previous ordering 
cycle.  This will potentially reduce the manpower needed to determine the actual inventory in 
stock on a continuous basis.  Due to the limitations in the dispensing data discussed above, 
the NNMC staff will need to conduct a regular inventory (e.g., annual) of each drug. 
Further, we recommend that NNMC apply this analysis to all of their drugs to 
identify areas of cost-savings / risk so that appropriate action can be taken. If possible, we 
recommend the command accomplish a full inventory to ascertain exactly what they 
currently have on hand in their system.  Overall, NNMC is performing admirably within the 
constraints of their systems.  By implementing the recommendations noted above, the 
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 APPENDIX A 
 
NNMC Pharmacy Flow Chart 
 
Ordering Process for an Individual Drug 
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*Indicates process steps that the Consultant Team believes could be improved 
If expired, the drug is 
discarded, returned to 
vendor, or extended 
via SLEP  
 
 
Dispensing Process for an Individual Drug 
Doctor orders drug  
through CHCS 
Patient does 




Picks up  





Unclaimed drugs periodically 
re-entered into CHCS 
* 
 *Indicates process steps that the Consultant Team believes could be improved 
